Will Novocure Stock Rebound After A Large 22% Fall In A Month?

Will Novocure Stock Rebound After A Large 22% Fall In A Month?

The stock price of Novocure, a company working on an innovative cancer treatment alternative using electric fields, has seen a fall of 15% in a week, while it is down 22% over the last month, following its downbeat Q3 results. The company reported sales of $134 million, up 4% y-o-y, but short…